The bis(tributylstannyl) derivative of 2′ ′,3′ ′didehydro-2′ ′,3′ ′-dideoxyuridine (d4U) underwent an anionic 5′ ′-O→3′ ′-C stannyl migration to yield the 3′ ′-tributylstannyl-d4U. This compound, with its vinylstannane structure, allowed ready access to the preparation of 3′ ′-carbon-substituted analogues through the Stille reaction. A conventional transformation of the uracil moiety of these d4U analogues led to the corresponding 2′ ′,3′ ′-didehydro-2′ ′,3′ ′-dideoxycytidine (d4C) counterparts. Some 2′ ′,3′ ′-dideoxycytidine (ddC) analogues were also synthesized. Antiviral evaluation revealed that none of these analogues showed activity against HIV, hepatitis B virus, herpes simplex virus-1 (HSV-1) and HSV-2.
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©2006 International Medical Press H-5), 5. m, m, 8.02 (1H, d, ; 119 Sn NMR (C 6 D 6 ) δ 58.70 , 85.42 (Bu 3 SnOSnBu 3 ), 100.45 (Bu 3 SnOMe), . . Compound 2, which was prepared from 150 mg (0.71 mmol) of 1 according to the above procedure, was dissolved in THF (6 ml) . This solution was added dropwise to a THF (7 ml) solution of LTMP (3.56 mmol, prepared from 2, 2, 6, tetramethylpiperidine and a hexane solution of BuLi) containing hexamethylphosphoric triamide (HMPA; 1.86 ml, 10.7 mmol) at −78°C under positive pressure of dry Ar. After being stirred for 20 min at −78°C, the reaction mixture was quenched by adding saturated aqueous NH 4 Cl. Extraction with EtOAc followed by column chromatography (hexane/EtOAc=2/1) gave 3 (177 mg, 50%) as a solid: mp 138-141°C; UV (MeOH) λ max 261 nm (ε 14,400) , λ min 235 nm (ε 6,600); 1 H NMR (CDCl 3 , after addition of D 2 O) δ 0.91 (9H, t, J=7.4 Hz, Sn(CH 2 ) 3 CH 3 ), 1. m, Sn(CH 2 ) 3 CH 3 ), 1. m, Sn(CH 2 ) 3 CH 3 ), 1. m, Sn(CH 2 ) 3 CH 3 ), 3.71 (1H, dd, J=3.8 and 12.0 Hz, 3.91 (1H, dd, J=3.0 and 12.0 Hz, m, 5.66 (1H, d, J=8.4 Hz, m, m, 7.95 (1H, d, J=8.4 Hz, ; 13 C NMR (CDCl 3 ) δ 9.91 (SnCH 2 (CH 2 ) 2 CH 3 ), 11.27 (Sn(CH 2 ) 3 CH 3 ), 27.25 and 29.03 (SnCH 2 (CH 2 ) 2 CH 3 ), 69.37 (C-5′), 90.35 (C-1′), 93.85 (C-4′), 102.16 (C-5), 133.72 (C-2′), 141.05 (C-6), 150.33 (C-3′), 150.71 (C-2), 163.44 (C-4) ; FAB-MS m/z 537 (M + +K for 118 Sn), 539 (M + +K for 120 Sn). Anal. Calcd for C 21 H 36 N 2 O 4 Sn: C, 50.53; H, 7.27; N, 5.61. Found: C, 50.74; H, 7.18; N, . This compound was isolated in 19% yield as a solid by HPLC purification (hexane/EtOAc=1/1, t R 8.9 min) when the above reaction for 3 was carried out in the presence of TMEDA (N,N,N,N-tetramethylethylenediamine; 5 equiv) instead of HMPA: mp 125-130 o C; UV (MeOH) λ max 267 nm (ε 10,200) , λ min 238 nm (ε 3,700); 1 H NMR (CDCl 3 , after addition of D 2 O) δ 0.89 (9H, t, J=7.2 Hz, Sn(CH 2 ) 3 CH 3 ), 1. m, Sn(CH 2 ) 3 CH 3 ), 1. m, Sn(CH 2 ) 3 CH 3 ), 1. m, Sn(CH 2 ) 3 CH 3 ), 3.75 (1H, dd, J=3.8 and 12.2 Hz, 3.89 (1H, dd, J=3.0 and 12.2 Hz, m, m, m, m, 7.32 (1H, s, ; 13 C NMR (CDCl 3 ) δ 9.81 (SnCH 2 (CH 2 ) 2 CH 3 ), 13.70 (Sn(CH 2 ) 3 CH 3 ), 27.26 and 28.95 (SnCH 2 (CH 2 ) 2 CH 3 ), 63.84 (C-5′), 87.03 (C-4′), 90.14 (C-1′), 112.90 (C-5), 126.66 (C-2′), 134.11 (C-3′), 144.36 (C-6), 151.45 (C-2), 166.22 (C-4) ; FAB-MS m/z 537 (M + +K for 118 Sn), 539 (M + +K for 120 Sn). Anal. Calcd for C 21 H 36 N 2 O 4 Sn: C, 50.53; H, 7.27; N, 5.61. Found: C, 50.74; H, 7.18; N, 5.59. Synthesis of 3′-phenyl-d4U (5) from 3, as a typical procedure. A mixture of 3 (185 mg, 0.37 mmol), PhI (124 µl, 1.11 mmol) , Pd(PPh 3 ) 4 (43 mg, 0.037 mmol) and CuI (14 mg, 0.074 mmol) in N, Ndimethylformamide (DMF; 1.5 ml) was stirred at room temperature for 19 h. The reaction mixture was partitioned between EtOAc and saturated aqueous NaHCO 3 . Column chromatography (EtOAc) of the organic layer gave 5 (85 mg, 81%) as a foam: UV λ max 256 nm (ε 21,400) , λ min 225 nm (ε 11,300) ; 1 H NMR (CDCl 3 ) δ 1. 66 (1H, t, J=5.6 Hz, OH), m, m, 5.72 (1H, dd, J=2.4 and 8.0 Hz, m, m, m, Ph), 7.91 (1H, d, J=8.0 Hz, 8.00 (1H, br, NH) ; FAB-MS m/z 287 (M + +H). Anal. Calcd for C 15 H 14 N 2 O 4 : C, 62.93; H, 4.93; N, 9.78. Found: C, 62.81; H, 5.15; N, . This compound was obtained as a foam in 58% yield by using 3 (310 mg, 0.62 mmol), PhCH 2 Br (221 µl, 1.86 mmol), Pd(PPh 3 ) 4 (107 mg, 0.09 mmol) and CuI (35 mg, 0.186 mmol) in DMF (1.8 ml) . The reaction was carried out at 70°C for 15 min: UV (MeOH) λ max 260 nm (ε 10,900), λ min 231 nm (ε 2,700); 1 H NMR (CDCl 3 ) δ 2.20 (1H, t, J=5.2 Hz, OH), 3.44 (1H, d, J=16.4 Hz, CH 2 Ph), 3.64 (1H, d, J=16.4 Hz, CH 2 Ph), 3.85 (1H, ddd, J=2.4, 5.2, and 12.4 Hz, 3.94 (1H, ddd, J=2.4, 5.2, and 12.4 Hz, 4.72 (1H, m, 5.35 (1H, m, 5.66 (1H, d, J=8.0 Hz, m, m, Ph), 7.74 (1H, d, J=8.0 Hz, 8.28 (1H, br, NH) ; FAB-MS m/z 301 (M + +H). Anal. Calcd for C 16 H 16 N 2 O 4 : C, 63.99; H, 9.33; N, 5.37. Found: C, 63.89; H, 9.28; N, . This compound was obtained as a foam in 56% yield by using 3 (180 mg, 0.36 mmol) , allyl bromide (125 µl, 1.44 mmol), Pd(PPh 3 ) 4 (42 mg, 0.036 mmol) and CuI (14 mg, 0.072 mmol) in DMF (1.8 ml) . The reaction was carried out at room temperature for 16 h: UV (MeOH) λ max 260 nm (ε 8,900), λ min 230 nm (ε 3,300); 1 H NMR (CDCl 3 , after addition of D 2 O) δ 2. m, CH 2 CH=CH 2 ), m, CH 2 CH=CH 2 ), 3.82 (1H, dd, J=2.4 and 12.4 Hz, 3.94 (1H, dd, J=2.4 and 12.4 Hz, 4.75 (1H, m, m, CH 2 CH=CH 2 ), 5.51 (1H, m, 5.67 (1H, d, J=8.0 Hz, m, CH 2 CH=CH 2 ), m, 7.74 (1H, d, J=8.0 Hz, ; FAB-MS m/z 251 (M + +H). Anal. Calcd for C 12 H 14 N 2 O 4 : C, 57.59; H, 5.64; N, 11.19. Found: C, 57.40; H, 5.45; N, . This compound was obtained as a solid in 66% yield by using 3 (308 mg, 0.616 mmol), 2-iodofluorobenzene (144 µl, 1.23 mmol), Pd(PPh 3 ) 4 (71 mg, 0.061 mmol) and CuI (23 mg, 0.12 mmol) in DMF (2.0 ml). The reaction was carried out at 70°C for 15 min: mp 92-96°C; UV (MeOH) λ max 250 nm (ε 22,200) , λ min 221 nm (ε 12,600); 1 H NMR (CDCl 3 , after addition of D 2 O) δ 3.83 (1H, dd, J=2.0 and 12.4 Hz, 3.97 (1H, dd, J=2.0 and 12.4 Hz, m, 5.72 (1H, d, J=8.0 Hz, 6.13 (1H, m, m, m, Ph), m, Ph), 7.90 (1H, d, J=8.0 Hz, O: C, 58.34; H, 4.41; N, 9.07. Found: C, 58.58; H, 4.56; N, . This compound was obtained as a foam in 97% yield by using 3 (200 mg, 0.40 mmol) , 3-iodofluorobenzene (140 µl, 1.23 mmol), Pd(PPh 3 ) 4 (46 mg, 0.04 mmol) and CuI (15 mg, 0.08 mmol) in DMF (1.5 ml) . The reaction was carried out at 70°C for 0.5 h: UV (MeOH) λ max 256 nm (ε 18,700) , λ min 223 nm (ε 7,400); 1 H NMR (CDCl 3 , after addition of D 2 O) δ 3.93 (1H, dd, J=2.4 and 12.8 Hz, 4.02 (1H, dd, J=2.0 and 12.8 Hz, m, 5.71 (1H, d, J=8.0 Hz, m, m, m, Ph), m, Ph), 7.89 (1H, d, J=8.0 Hz, ; FAB-MS m/z 343 (M + +K). Anal. Calcd for C 15 H 13 FN 2 O 4 : C, 59.21; H, 4.31; N, 9.21. Found: C, 58.85; H, 4.39; N, 8.89. 3′-(4-Fluorophenyl)-d4U (10). This compound was obtained as a solid in 86% yield by using 3 (554 mg, 1.10 mmol), 4-iodofluorobenzene (253 µl, 2.20 mmol), Pd(PPh 3 ) 4 (127 mg, 0.11 mmol) and CuI (42 mg, 0.22 mmol) in DMF (2.0 ml). The reaction was carried out at room temperature for 46 h: mp 99-106°C; UV λ max 256 nm (ε 21,200) , λ min 223 nm (ε 7,800); 1 H NMR (CDCl 3 , after addition of D 2 O) δ 3.90 (1H, dd, J=2.4 and 12.4 Hz, 4.00 (1H, dd, J=2.0 and 12.4 Hz, 5.34 (1H, m, 5.71 (1H, d, J=8.4 Hz, 5.97 (1H, m, m, m, Ph), 7.89 (1H, d, J=8.4 Hz, O: C, 58.52; H, 4.39; N, 9.10. Found: C, 58.87; H, 4.53; N, . This compound was obtained as a solid in 79% yield by using 3 (200 mg, 0.40 mmol), 2-iodoanisole (156 µl, 1.20 mmol) , Pd(PPh 3 ) 4 (69 mg, 0.06 mmol) and CuI (22 mg, 0.12 mmol) in DMF (2.0 ml). The reaction was carried out at 70°C for 20 min: mp 245-258°C; UV (MeOH) λ max 254 nm (ε 20,600), λ min 232 nm (ε 11,100); 1 H NMR (CDCl 3 , after addition of 75 (1H, dd, J=2.8 and 12.8 Hz, m, m, 5.73 (1H, d, J=8.0 Hz, 6.05 (1H, m, m, Ph), m, m, Ph), 7.95 (1H, d, J=8.0 Hz, ; FAB-MS m/z 317 (M + +H). Anal. Calcd for C 16 H 16 N 2 O 5 : C, 60.76; H, 5.10; N, 8.86. Found: C, 60.55; H, 4.95; N, . This compound was obtained as a solid in 86% yield by using 3 (482 mg, 0.97 mmol), 3-iodoanisole (344 µl, 2.91 mmol), Pd(PPh 3 ) 4 (167 mg, 0.14 mmol) and CuI (55 mg, 0.28 mmol) in DMF (2.0 ml). The reaction was carried out at 70°C for 0.5 h: mp 158-168°C; UV (MeOH) λ max 258 nm (ε 23,100), λ min 236 nm (ε 14,500); 1 H NMR (CDCl 3 ) δ 1.62 (1H, t, J=6.2 Hz, OH), 3.84 (3H, s, OMe), m, 5.35 (1H, m, 5.73 (1H, d, J=8.0 Hz, 6.02 (1H, m, m, Ph), 7.10 (1H, m, m, Ph), 7.91 (1H, d, J=8.0 Hz, 7.98 (1H, br, NH) ; FAB-MS m/z 317 (M + +H). Anal. Calcd for C 16 H 16 N 2 O 5 : C, 60.76; H, 5.10; N, 8.86. Found: C, 60.15; H, 4.91; N, 8.86. 3′- . This compound was obtained as a solid in 91% yield simply by reacting 3 with iodine (1.5 equiv) in THF for 4 h at room temperature: mp 147-155°C; UV (MeOH) λ max 260 nm (ε 10,500), λ min 235 nm (ε 2,900); 1 H NMR (CDCl 3 ) δ 1.93 (1H, s, OH), each as m, m, 5.70 (1H, d, J=8.0 Hz, 6.23 (1H, m, m, 7.80 (1H, d, J=8.0 Hz, 8.17 (1H, br, NH) ; FAB-MS m/z 337 (M + +H). Anal. Calcd for C 9 H 9 IN 2 O 4 : C, 32.16; H, 2.70; N, 8.34. Found: C, 32.30; H, 2.41; N, . This compound was obtained as a form in 52% yield by using 13 (110 mg, 0.33 mmol), CH 2 =CHSnBu 3 (286 µl, 0.98 mmol), Pd(PPh 3 ) 4 (38 mg, 0.033 mmol) and CuI (12 mg, 0.065 mmol) in DMF (1.5 ml). The reaction was carried out at 70°C for 15 min: UV (MeOH) λ max 259 nm (ε 8,000), λ min 232 nm (ε 4,500); 1 H NMR (CDCl 3 ) δ 3.97 (2H, m, H-5′), 5.06 (1H, m, m, CH=CH 2 ), 5.64 (1H, d, J=8.0 Hz, 5.76 (1H, m, 6.53 (1H, dd, J=11.2 and 18.0 Hz, CH=CH 2 ), 6.97 (1H, m, 7.81 (1H, d, J=8.0 Hz, 8.04 (1H, br, NH) ; FAB-MS m/z 237 (M + +H). Anal. Calcd for C 11 H 12 N 2 O 4 • 1/2H 2 O: C, 53.87; H, 5.34; N, 11.42. Found: C, 54.18; H, 5.49; N, 11.30. 5′-O-Acetyl- 3′-phenyl-d4U (15) . This compound was obtained as a foam: 1 H NMR (CDCl 3 ) δ 1.99 (3H, s, Ac), 4.28 (1H, dd, J=4.4 and 12.6 Hz, 4.44 (1H, dd, J=2.2 and 12.6 Hz, m, 5.75 (1H, dd, J=2.0 and 8.0 Hz, m, m, Ph), 7.62 (1H, d, J=8.0 Hz, 8.57 (1H, br, NH) ; FAB-MS m/z 329 (M + +H). Anal. Calcd for C 17 H 16 N 2 O 5 : C, 62.19; H, 4.91; N, 8.53. Found: C, 62.04; H, 4.55; N, 8.45. 5′-O-Acetyl- 3′-benzyl-d4U (16) . This compound was obtained as a foam: 1H NMR (CDCl 3 ) δ 2.05 (3H, s, Ac), 3.42 and 3.57 (2H, each as d, J=16.8 Hz, CH 2 Ph), 4.26 (1H, dd, J=2.4 and 13.0 Hz, 4.35 (1H, dd, J=3.0 and 13.0 Hz, m, 5.47 (1H, m, 5.68 (1H, d, J=8.4 Hz, m, m, Ph), 7.52 (1H, d, J=8.4 Hz, 8.21 (1H, br, NH) ; FAB-MS m/z 343 (M + +H). Anal. Calcd for C 18 H 18 N 2 O 5 •1/2H 2 O: C, 61.53; H, 5.45; N, 7.97. Found: C, 61.56; H, 5.12; N, 7.81. 5′-O-Acetyl- 3′-allyl-d4U (17) . This compound was obtained as a foam: 1 H NMR (CDCl 3 , after addition of D 2 O) δ 2.08 (3H, s, Ac), 2.84-2.90 and 2.95-3.01 (2H, each as m, CH 2 CH=CH 2 ), 4. m, m, m, CH 2 CH=CH 2 ), m, 5.70 (1H, d, J=8.4 Hz, m, CH 2 CH=CH 2 ),b6. m, 7.52 (1H, d, J=8.4 Hz, ; FAB-MS m/z 331 (M + +H). Anal. Calcd for C 14 H 16 N 2 O 5 : C, 57.53; H, 5.52; N, 9.58. Found: C, 57.32; H, 5.30; N, 9.54. 5′-O-Acetyl-3′-(2-fluorophenyl)-d4U (18). This compound was obtained as a solid: mp 178-182°C; 1 H NMR (CDCl 3 ) δ 1.99 (3H, s, Ac), 4.27 (1H, dd, J=3.8 and 12.6 Hz, 4.35 (1H, dd, J=2.4 and 12.6 Hz, m, 5.75 (1H, d, J=8.0 Hz, 6.17 (1H, m, m, m, Ph), m, Ph), 7.65 (1H, d, J=8.0 Hz, 8.67 (1H, br, NH) ; FAB-MS m/z 347 (M + +H). Anal. Calcd for C 17 H 15 FN 2 O 5 : C, 58.96; H, 4.37; N, 8.09. Found: C, 58.71; H, 4.13; N, 7.97 . (19). This compound was obtained as a solid: mp 183-186°C; 1 H NMR (CDCl 3 ) δ 2.01 (3H, s, Ac), 4.30 (1H, dd, J=4.2 and 12.8 Hz, 4.43 (1H, dd, J=2.4 and 12.8 Hz, m, 5.75 (1H, d, J=8.4 Hz, m, m, m, Ph), 7.60 (1H, d, J=8.4 Hz, 8.50 (1H, br, NH) ; FAB-MS m/z 347 (M + +H). Anal. Calcd for C 17 H 15 FN 2 O 5 : C, 58.96; H, 4.37; N, 8.09. Found: C, 58.98; H, 4.18; N, 7.89. 5′-O-Acetyl-3′-(4-fluorophenyl)-d4U (20) . This compound was obtained as a foam: 1 H NMR (CDCl 3 ) δ 2.01 (3H, s, Ac), 4.27 (1H, dd, J=4.4 and 12.6 Hz, 4.43 (1H, dd, J=2.4 and 12.6 Hz, m, 5.75 (1H, d, J=8.0 Hz, m, m, m, Ph), m, Ph), 7.60 (1H, d, J=8.0 Hz, 8.50 (1H, br, NH) ; FAB-MS m/z 347 (M + +H). Anal. Calcd for C 17 H 15 FN 2 O 5 : C, 58.96; H, 4.37; N, 8.09. Found: C, 58.93; H, 4.17; N, 7.90 . (21). This compound was obtained as a solid: mp 146-151°C; 1 H NMR (CDCl 3 ) δ 2.01 (3H, s, Ac), 3.85 (3H, s, OMe), 4.27 (1H, dd, J=4.4 and 12.8 Hz, 4.45 (1H, dd, J=2.0 and 12.8 Hz, m, 5.74 (1H, d, J=8.0 Hz, m, m, Ph), m, m, Ph), 7.61 (1H, d, J=8.0 Hz, 8.35 (1H, br, NH) ; FAB-MS m/z 397 (M + +K). Anal. Calcd for C 18 H 18 N 2 O 6 : C, 60.33; H, 5.06; N, 7.82. Found: C, 59.96; H, 4.98; N, 7.46. Synthesis of 3′-phenyl-d4C (22) from 15, as a typical procedure. To a suspension containing 1,2,4triazole (215 mg, 3.12 mmol) , POCl 3 (64 µl, 0.69 mmol), and CH 3 CN (3 ml) was added Et 3 N (435 µl, 3.12 mmol) dropwise at 0°C under positive pressure of dry Ar. A CH 3 CN (2 ml) solution of 15 (114 mg, 0.35 mmol) was added to the above mixture and the whole mixture was stirred for 3 h at 0°C. The reaction mixture was quenched by adding Et 3 N (250 µl) and then H 2 O (3 ml); the mixture was then evaporated, and partitioned between CHCl 3 and saturated aqueous NaHCO 3 . The organic layer was evaporated, and the residue was dissolved in 1,4-dioxane (1.8 ml) . The resulting solution was reacted with 28%NH 3 /H 2 O (300 µl) at room temperature overnight, and then evaporated to dryness. The residue was dissolved in NH 3 /MeOH (ca. 10 ml) and kept in a refrigerator overnight. After being evaporated, the reaction mixture was purified by column chromatography (CHCl 3 / MeOH=5/1). This gave 22 (74 mg, 75%) as a solid: mp 271-279°C; UV (MeOH) λ max 248 nm (ε 19,400) , λ min 222 nm (ε 8,900); 1 H NMR (DMSO-d 6 , after addition of D 2 O) δ 3. m, m, 5.81 (1H, d, J=7.6 Hz, 6.21 (1H, m, m, m, Ph), m, Ph), 7.96 (1H, d, J=7.6 Hz, O: C, 62.75; H, 5.33; N, 14.63. Found: C, 62.65; H, 5.09; N, . This compound was obtained as a foam in 59% yield from 16: λ max 273 nm (ε 6,600), λ min 228 nm (ε 3,000); 1 H NMR (DMSO-d 6 ) δ 3. m, CH 2 Ph), m, 4.55 (1H, m, 5.02 (1H, t, J=5.2 Hz, OH), 5.31 (1H, m, 5.66 (1H, d, J=7.2 Hz, m, 7.95 and 8.01 (2H, each as br, NH 2 ), m, Ph), m, Ph), 7.82 (1H, d, J=7.2 Hz, O: C, 60.55; H, 6.03; N, 13.24. Found: C, 60.49; H, 5.87; N, . This compound was obtained as a solid in 59% yield from 17: mp 161-166°C; λ max 271 nm (ε 9,600), λ min 255 nm (ε 8,300); 1 H NMR (DMSO-d 6 , after addition of D 2 O) δ 2.87 and 3.01 (2H, each as dd, J=6.4 and 17.0 Hz, CH 2 CH=CH 2 ), 3. m, 4.65 (1H, m, m, CH 2 CH=CH 2 ), 5.51 (1H, m, 5.76 (1H, d, J=7.4 Hz, m, CH 2 CH=CH 2 ), 6. m, 7.85 (1H, d, J=7.4 Hz, ; FAB-MS m/z 250 (M + +H). Anal. Calcd for C 12 H 15 N 3 O 3 : C, 57.82; H, 6.07; N, 16.86. Found: C, 57.60; H, 5.95; N, . This compound was obtained as a foam in 57% yield from 18: λ max 242 nm (ε 24,000), λ min 221 nm (ε 16,200) ; 1 H NMR (DMSO-d 6 , after addition of D 2 O) δ 3. each as m, m, 5.70 (1H, d, J=7.6 Hz, m, m, m, Ph), m, Ph), m, Ph), 7.90 (1H, d, J=7.6 Hz, O: C, 58.53; H, 4.75; N, 13.65. Found: C, 58.21; H, 4.45; N, 13.65. 
3′-(3-Fluorophenyl)-d4C (26). This compound was
obtained as a solid in 73% yield from 19: mp 186-193°C; λ max 246 nm (ε 23,900), λ min 223 nm (ε 16,000); 1 H NMR (DMSO-d 6 ) δ 3. m, 4.90 (1H, t, J=4.5 Hz, OH), m, 5.68 (1H, d, J=7.6 Hz, m, m, m, Ph and NH 2 ), m, Ph), 7.90 (1H, d, J=7.6 Hz, O: C, 58.53; H, 4.75; N, 13.65. Found: C, 58.86; H, 5.07; N, 13.66. 
3′-(4-Fluorophenyl)-d4C (27). This compound was
obtained as a foam in 42% yield from 20: λ max 248 nm (ε 18,700), λ min 221 nm (ε 7,600); 1 H NMR (DMSO-d 6 ) δ 3. m, 4.88 (1H, t, J=4.5 Hz, OH), 5.29 (1H, m, 5.67 (1H, d, J=7.4 Hz, 6.21 (1H, m, m, 7.10 and 7.16 (2H, each as br, NH 2 ), m, Ph), m, Ph), 7.90 (1H, d, J=7.4 Hz, O: C, 58.53; H, 4.75; N, 13.65. Found: C, 58.32; H, 4.45; N, 13.67. 
3′-(3-Methoxyphenyl)-d4C (28). This compound was
obtained as a foam in 67% yield from 21: λ max 254 nm (ε 16,100), λ min 236 nm (ε 12,300); 1 H NMR (DMSO-d 6 ) δ 3. m, 3.78 (3H, s, OMe), 4.89 (1H, t, J=4.4 Hz, OH), m, 5.69 (1H, d, J=7.6 Hz, m, m, Ph), (1H, m, H-1′) , 7. m, Ph), 7.11 and 7.17 (2H, each as br, NH 2 ), m, Ph), 7.91 (1H, d, J=7.6 Hz, ; FAB-MS m/z 316 (M + +H). Anal. Calcd for C 16 H 17 N 3 O 4 : C, 60.94; H, 5.43; N, 13.33. Found: C, 60.66; H, 5.33; N, 13.22. Synthesis of 3′-β-phenyl-ddC (29) from 15, as a typical procedure. Catalytic hydrogenation of 15 (430 mg, 1.30 mmol) was carried out in EtOH (6 ml): EtOAc (6 ml) in the presence of 5% Pd-C (175 mg) at room temperature for 4 days. Filtration of the reaction mixture followed by evaporation gave the product (379 mg, 88%), which was dissolved in CH 3 CN (23 ml). To this solution were added 2,4,6-triisopropylbenzenesulphonyl chloride (690 mg, 2.28 mmol), 4-dimethylaminopyridine (278 mg, 2.28 mmol), and Et 3 N (317 µl, 2.28 mmol) at 0°C under positive pressure of dry Ar. The sulphonylation mixture was stirred at room temperature for 3 h and then treated with 28% aqueous NH 3 (18 ml) for 1.5 h. The reaction mixture was evaporated to dryness. The residue was dissolved in CH 2 Cl 2 (10 ml), reacted with Ac 2 O (500 µl) at 0°C for 0.5 h in the presence of i-Pr 2 NEt (577 µl) and 4-dimethylaminopyridine (121 mg), and then partitioned between CHCl 3 and saturated aqueous NaHCO 3 . Column chromatography (CHCl 3 /MeOH=30/1) of the organic layer gave the N 4 ,5′-O-diacetate (396 mg). The diacetate (370 mg) was dissolved in NH 3 /MeOH (30 ml) and the solution was kept in a refrigerator for 6 days. Evaporation of the solvent gave 29 (287 mg, overall yield from 15: 81%) as a foam: UV (MeOH) λ max 273 nm (ε 9,500), λ min 252 nm (ε 7,300); 1 H NMR (DMSO-d 6 ) δ 2. each as m, m, m, m, 4.66 (1H, t, J=4.2 Hz, OH), 5.75 (1H, d, J=7.6 Hz, 6.13 (1H, dd, J=5.2 and 8.8 Hz, 7.09 and 7.15 (2H, each as br, NH 2 ), m, Ph), 8.05 (1H, d, J=7.6 Hz, O: C, 61.73; H, 6.04; N, 14.40. Found: C, 61.93; H, 5.97; N, . This compound was obtained as a foam with 61% overall yield from 16: UV (MeOH) λ max 277 nm (ε 7,000), λ min 256 nm (ε 3,400); 1 H NMR , after addition of D 2 O) δ 1.78 (1H, ddd, J=2.4, 7.2, and 13.6 Hz, 2.10 (1H, ddd, J=7.2, 10.2, and 13.6 Hz, m, m, CH 2 Ph), 2.80 (1H, dd, J=4.8 and 13.2 Hz, CH 2 Ph), m, m, 5.64 (1H, d, J=7.6 Hz, 5.88 (1H, dd, J=2.4 and 10.2 Hz, m, Ph), 7.99 (1H, d, J=7.6 Hz, O: C, 61.92; H, 6.49; N, 13.53. Found: C, 61.86; H, 6.58; N, . This compound was obtained as a solid in 59% overall yield from 18: mp 219-223°C; UV (MeOH) λ max 269 nm (ε 10,000), λ min 251 nm (ε 7,500); 1 H NMR (DMSO-d 6 , after addition of D 2 O) δ 2. m, 3.09 (1H, dd, J=5.2 and 11.6 Hz, 3.22 (1H, dd, J=2.6 and 11.6 Hz, m, m, 5.78 (1H, d, J=7.2 Hz, 6.17 (1H, dd, J=5.6 and 8.8 Hz, m, Ph), m, Ph), 8.05 (1H, d, J=7.2 Hz, O: C, 58.66; H, 5.31; N, 13.68. Found: C, 58.56; H, 5.17; N, . This compound was obtained as a foam with 33% overall yield from 19: UV (MeOH) λ max 270 nm (ε 7,600), λ min 227 nm (ε 2,300); 1 H NMR (DMSO-d 6 ) δ 2. each as m, m, 3.85 (1H, dt, J=7.6 and 12.8 Hz, m, 4.71 (1H, t, J=4.0 Hz, OH), 5.76 (1H, d, J=7.4 Hz, 6.14 (1H, dd, J=5.2 and 8.8 Hz, m, Ph), m, Ph and NH 2 ), m, Ph), 8.06 (1H, d, J=7.4 Hz, O: C, 55.72; H, 5.29; N, 12.99. Found: C, 55.89; H, 5.16; N, . This compound was obtained as a foam in 47% overall yield from 20: UV (MeOH) λ max 272 nm (ε 7,500), λ min 226 nm (ε 2,200); 1 H NMR (DMSO-d 6 ) δ 2.31 (1H, ddd, J=8.8, 12.2, and 12.8  Hz, H-2′), 2.42-2.48 (1H, m, H-2′), 3.10-3.16 and  3.18-3.23 (2H, each as m, H-5′), 3.81 (1H, m, H-37) , 4.28 (1H, ddd, J=3.2, 5.2, and 8.4 Hz, 4.68 (1H, t, J=4.2 Hz, OH), 5.75 (1H, d, J=7.4 Hz, 6.13 (1H, dd, J=5.2 and 8.8 Hz, m, Ph and NH 2 ), m, Ph), 8.06 (1H, d, J=7.4 Hz, ; FAB-MS m/z 306 (M + +H). Anal. Calcd for C 15 H 16 FN 3 O 3 • H 2 O: C, 55.72; H, 5.29; N, 12.99. Found: C, 56.00; H, 5.17; N, 12.65. Virology HIV assay. The HIV assay is performed in RPMI 1640 medium containing 10% dialysed fetal bovine serum and 100 µg/ml kanamycin using MT-2 cells. HIV-1, strain IIIB, is grown in H9 cells, titred and added to MT-2 cells at 0.1 multiplicity of infection. One hundred microlitres of compounds are added to the individual wells of a 96-well plate, which contained infected or uninfected MT 2 cells at a density of 10 5 cells/ml. After 5 days at 37°C in a 5% CO 2 incubator, the assay is ended with the addition of 20 µl/well of MTT dye (2.5 mg/ml) and a final incubation period of 4 h. The colour is developed by the addition of isopropanol containing 2% NP-40 and 170 µl of conc HCl per 50 ml. The next day the microplate is read at 595 nm on a spectrophotometer and the drug-treated wells, infected and uninfected, are compared to the uninfected, untreated control wells. All reactions were carried out by using 5 equiv of lithiating agents at -78°C for 20 min. HMPA, hexamethylphosphoric triamide; LDA, lithium diisopropylamide; LTMP, lithium 2,2,6,6-tetramethylpiperidide; TMEDA, N,N,N,N-tetramethylethylenediamine. 
Results
The starting material d4U (1) was prepared according to the published procedure (Mansuri et al., 1989) .
Transalkoxylation between Bu 3 SnOMe (Saigo et al., 1976) and 1 was carried out simply by heating them together neat at 90 o C as shown in Figure 1 . The resulting bis(tributylstannyl)-d4U (2) is not stable enough to be isolated in pure form, but its 1 H NMR spectrum measured in benzene-d 6 showed that it consisted of a single isomer, and that the 5′-O-Sn bond was certainly present: the two H-5′ resonances (δ 3.59 and 3.85) appeared as ddd, because of additional coupling with 119 Sn (J Sn-5′ =27. 6 and 32.8 Hz, respectively) . The depicted structure of 2 (Ogawa & Matsui, 1981) was further confirmed by its 119 Sn NMR spectrum, which gave two resonances derived from 2 (δ 58.70 and 106.65) in addition to two other signals from (Bu 3 Sn) 2 O (δ 85.42) and Bu 3 SnOMe (δ 100.45). Regiochemistry of 2 was deduced from its HMBC (Heteronuclear Multiple Bond Connectivity) spectrum, wherein both H-1′ and H-5′ showed correlations with a quaternary carbon atom (C-3′). When 2 was reacted with LTMP in THF in the presence of HMPA as well as TMEDA, as reported in the case of the d4T analogue (Kumamoto et al., 2002) , the desired 3′-tributylstannyl derivative (3) was obtained in 50% (entry 1 in Table 1 ). The absence of HMPA in this stannyl migration reaction decreased the yield of 3 significantly and the isomeric 5-tributylstannyl derivative (4) was formed in 19% yield (entry 2). In contrast to HMPA, which presumably increases reactivity of the incipient 3′-vinyllithium intermediate through solvation, TMEDA does not play a crucial role in this reaction as evidenced by entry 3. The less basic lithium diisopropylamide, which is known to effect lithiation at the 6-position of uridine derivatives (Tanaka et al., 1999) , did not give the expected 6-tributylstannyl derivative, but simply decreased the yield of 3 (entry 4).
Having established a method to obtain 3 in a reasonable yield (entry 3 in Table 1 ), we next examined its transformation to the 3′-carbon-substituted analogues through the use of the Stille reaction (Mitchell, 1992) . As shown in Figure 2 and in Table 2 , the reaction of 3 with iodobenzene derivatives (entries 1 and 4-8), benzyl bromide (entry 2) and allyl bromide (entry 3) all gave good to excellent yields of the corresponding coupling products. It is worth mentioning that the present method requires only three steps (stannylation of d4U, anionic stannyl migration and the Stille reaction) from d4U to its 3′-carbon-substituted analogues. As 3 underwent iodination simply by reacting with iodine in THF, it is also possible to react the resulting 3′-iodo-d4U (13, obtained in 91% yield from 3) with organotin reagents. This was exemplified by the preparation of 3′-vinyl-d4U (14) by reacting 13 with CH 2 =CHSnBu 3 .
Conversion of the above prepared 3′-carbon-substituted d4U derivatives to the cytidine analogues was carried out by the triazole method (Divakar & Reese, 1982) . Compounds 5-10 and 12 were acetylated by Ac 2 O in pyridine to give the respective 5′-O-acetates (15-21; Figure 3) .
The respective acetate was reacted with a mixture of POCl 3 and 1,2,4-triazole according to the published method (Divakar & Reese, 1982) . Ammonolysis of the resulting 4- (1,2,4-triazol-1-yl) derivatives was carried out with 28% NH 4 OH. Removal of the 5′-O-acetyl group with NH 3 /MeOH led to the desired d4C analogues (22-28; Figure 3) .
We also carried out the synthesis of 3′-carbon-substituted ddC analogues (29) (30) (31) (32) (33) as shown in Figure 4 . As can be expected from the presence of the base moiety as well as the 4′-CH 2 OAc group, catalytic hydrogenation of the 5′-Oacetyl-d4U derivatives (15, 16, and 18-20) occurred stereoselectively to give the 3′-β-carbon-substituted products. This time, the conversion of these products to the cytosine analogues was carried out through 4-O-sulphonylation with 2,4,6-triisopropylbenzenesulphonyl chloride (TPSCl) in the presence of 4-dimethylaminopyridine and subsequent ammonolysis (Gaffney et al., 1984) . The reaction mixture containing the desired ddC analogues was acetylated and then purified by silica gel column chromatography. This gave the respective N 4 ,5′-O-diacetyl derivative, which was then treated with NH 3 /MeOH. The present five steps reaction sequence produced overall yields of the 3′-carbon-substituted ddC analogues (29) (30) (31) (32) (33) ranging from 33% to 81%.
Stereochemistry of the initial catalytic hydrogenation step in Figure 4 was confirmed at this stage by measuring NOE of the ddC analogues. The results are exemplified by 29 and 31 in Figure 5 .
Discussion
Although d4U is reported to be practically inactive, d4C exhibits an excellent anti-HIV activity that is comparable to d4T (Chu et al., 1988) . Also, its saturated analogues ddC is know to be the most potent anti-HIV agent among 2′,3′-dideoxynucleosides with natural nucleobases (Mitsuya et al., 1986) . However, their 3′-carbon substituted analogues (d4U, 6-13; d4C, 22-28; ddC, 29-33 ) synthesized in the present study were found to be uniformly inactive. These compounds were also tested for their inhibitory activity against HBV (Doong et al., 1991) , HSV-1 and HSV-2 (Cheng et al., 1980; Gao et al., 1990) . Unfortunately, no appreciable antiviral activity was seen also against these viruses. 
